Richard A. Lewis, M.D.

Education: Union College, New York BS 1970; Medical College of Virginia,VCU 1974

Internship: Hartford Hospital, Hartford, CT 1974-75

Board Certifications: American Board of Psychiatry and Neurology (Neruology) 1980; Added Qualification in Clinical Neurophysiology 1996; American Board of Electrodiagnostic Medicine 1985

Prior Appointments: University of Pennsylvania, 1978-80; University of Connecticut Health Center, 1980-83; Eastern Virginia Medical School

WSU Appointments: Professor and Associate Chairman of Neurology

Honors: American Neurological Association, Elected Member; Best Doctors in America, Midwest, 1998-2001; Best Doctors in America, 2000-2001; Detroit Free Press Best Doctors in Detroit, 1995-2000; Hour Magazine Best Doctors (Neurolgy), 2001; Best Teachers in America, 2002

Subspecialty Interests: Director of Clinical Neurophysiology (Holden Lab); Neuromuscular Diseases; Electromyography; Peripheral Neuropathy; Myasthenia Gravis; Amyotrophic Lateral Sclerosis; Neurosarcoidosis

View Complete CV for Dr. Lewis (PDF)

Select CIDP Publications by Richard A. Lewis, M.D.

Links that appear on this page will cause you to exit this site and go to the PubMed site. These links provide additional information that may be useful or interesting, and is being provided consistent with the intended purpose of the CIDP Information Center. However, as the sponsor of the CIDP Information Center, Talecris Biotherapeutics cannot attest to the accuracy of information provided by this link and assumes no responsibility or liability for the contents provided by this link.

To return to the CIDP Information Center, use the back button in your browser or bookmark this page.

• Mendell JR, Barohn RJ, Freimer ML, Kissel JT, King W, Campbell WW, Donofrio PD, Jackson CE, Lewis RA, Shy M, Simpson DM, Parry G, Rivner MH, Thornton CA, Bromberg MB, Tanden R, Wrubel BT, Harati Y, Giuliani MJ and the working group on peripheral neuropathy. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 56:445-449, 2001.
• Khan OA, Tselis AC, Kamholz JA, Garbern JY, Lewis RA, Lisak RP. A prospective, open-label trial to compare the effect of IFNbeta-1A (Avonex), IFNbeta-1b (Betaseron) and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis: results after 18 months of therapy. Mult Scler 7:349-53, 2001.
• Lewis RA, Sumner AJ, Shy ME,. Electrophysiologic features of inherited demyelinating neuropathies: a reappraisal in the era of molecular genetics. Muscle Nerve 23; 1472-1487, 2000.
• Li J, Krajewski K, Shy ME, Lewis RA. Hereditary neuropathy with liability to pressure palsy: the electrophysiology fits the name. Neurology 58:1769-73, 2002.
• Zhou L, Zabad R, Lewis RA. Ethylene glycol intoxication: Electrophysiological studies suggest a polyradiculopathy. Neurology 59:1809- 10, 2002.
• Olney RK, Lewis RA, Putnum TD, Campellone JV jr. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 27:117-121, 2003.
• Shy ME, Boespflug-Tanguy O, Hobson G, Garbern J, Sprenkle K, Jan M, Li W, Gow A, Rodriguez D, Mancini P, Pertini E, Krajewski K, Lewis RA, Kamholz J. Schwann cell expression of the PLP1 specific domain is necessary for normal peripheral nerve function. Ann Neurol 53:354-365, 2003.
• Shy ME, Jani A, Krajewski K, Grandis M, Lewis RA, Li J, Shy RR, Balsamo J, Lilien J, Garbern JY, Kamholz J. Phenotypic clustering in MPZ mutations. Brain 127:1-14, 2004.
• Li j, Krajewski K, Lewis RA, Shy ME. Loss-of-function phenotype of hereditary neuropathy with liability to pressure palsies. Muscle Nerve 29:205-10, 2004.
• England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, Cohen JA, Fisher MA, Howard JF, Kinsella LJ, Latov N, Lewis RA, Low PA, Sumner AJ. Distal symmetrical polyneuropathy: Definition for clinical research. Muscle Nerve. 31:113-123; Arch Phys Med Rehabil. 86:167-74; Neurology. 64:199-207, 2005.

To view all publications by Richard A. Lewis, visit PubMed.